Table of Contents Author Guidelines Submit a Manuscript
International Journal of Dentistry
Volume 2014, Article ID 192320, 5 pages
http://dx.doi.org/10.1155/2014/192320
Review Article

Bisphosphonate-Related Osteonecrosis of the Jaw: A Review of the Literature

1Department of Oral and Maxillofacial Surgery, Piracicaba Dental School, P.O. Box 52, University of Campinas (UNICAMP), 13414-903 Piracicaba, SP, Brazil
2Department of Dental Radiology, Piracicaba Dental School, P.O. Box 52, University of Campinas (UNICAMP), 13414-903 Piracicaba, SP, Brazil
3Department of Prosthesis and Periodontology, Piracicaba Dental School, P.O. Box 52, University of Campinas (UNICAMP), 13414-903 Piracicaba, SP, Brazil

Received 21 February 2014; Accepted 9 April 2014; Published 28 April 2014

Academic Editor: Giuliano Ascani

Copyright © 2014 Eder Alberto Sigua-Rodriguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Fleisch, “Bisphosphonates: mechanisms of action,” Endocrine Reviews, vol. 19, no. 1, pp. 80–100, 1998. View at Google Scholar · View at Scopus
  2. J. R. Green, “Bisphosphonates: preclinical review,” The Oncologist, vol. 9, supplement 4, pp. 3–13, 2004. View at Google Scholar · View at Scopus
  3. S. Barni, M. Mandalá, M. Cazzaniga, M. Cabiddu, and M. Cremonesi, “Bisphosphonates and metastatic bone disease,” Annals of Oncology, vol. 17, supplement 2, pp. ii91–ii95, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Fleisch, R. G. Russell, and M. D. Francis, “Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo,” Science, vol. 165, no. 3899, pp. 1262–1264, 1969. View at Google Scholar · View at Scopus
  5. S. A. Guttenberg, “Bisphosphonates and bone...what have we learned?” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 106, no. 6, pp. 769–772, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Vahtsevanos, A. Kyrgidis, E. Verrou et al., “Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw,” Journal of Clinical Oncology, vol. 27, no. 32, pp. 5356–5362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. E. Marx, Y. Sawatari, M. Fortin, and V. Broumand, “Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment,” Journal of Oral and Maxillofacial Surgery, vol. 63, no. 11, pp. 1567–1575, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Saia, S. Blandamura, G. Bettini et al., “Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction,” Journal of Oral and Maxillofacial Surgery, vol. 68, no. 4, pp. 797–804, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. L. Ruggiero, T. B. Dodson, L. A. Assael, R. Landesberg, R. E. Marx, and B. Mehrotra, “American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update,” Journal of Oral and Maxillofacial Surgery, vol. 67, no. 5, pp. 2–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. H. Lin, D. E. Duggan, I.-W. Chen, and R. L. Ellsworth, “Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals,” Drug Metabolism and Disposition, vol. 19, no. 5, pp. 926–932, 1991. View at Google Scholar · View at Scopus
  11. C. Walter, K. A. Grötz, M. Kunkel, and B. Al-Nawas, “Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis,” Supportive Care in Cancer, vol. 15, no. 2, pp. 197–202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. D. Vasikaran, “Bisphosphonates: an overview with special reference to alendronate,” Annals of Clinical Biochemistry, vol. 38, no. 6, pp. 608–623, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. N. P. Fernández, R. E. Fresco, and J. M. A. Urizar, “Bisphosphonates and oral pathology I. General and preventive aspects,” Medicina Oral, Patología Oral y Cirugía Bucal, vol. 11, no. 5, pp. E396–E400, 2006. View at Google Scholar · View at Scopus
  14. G. A. Rodan and H. A. Fleisch, “Bisphosphonates: mechanisms of action,” The Journal of Clinical Investigation, vol. 97, no. 12, pp. 2692–2696, 1996. View at Google Scholar · View at Scopus
  15. P. Fournier, S. Boissier, S. Filleur et al., “Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats,” Cancer Research, vol. 62, no. 22, pp. 6538–6544, 2002. View at Google Scholar · View at Scopus
  16. M. Goffinet, M. Thoulouzan, A. Pradines et al., “Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells,” BMC Cancer, vol. 6, article 60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. L. Ruggiero, J. Fantasia, and E. Carlson, “Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 102, no. 4, pp. 433–441, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. E. Marx, “Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic,” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 9, pp. 1115–1117, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. L. Ruggiero, B. Mehrotra, T. J. Rosenberg, and S. L. Engroff, “Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases,” Journal of Oral and Maxillofacial Surgery, vol. 62, no. 5, pp. 527–534, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Bertè, A. Arcari, P. Bernuzzi et al., “Jaw avascular bone necrosis associated with long-term use of bisphosphonates,” Tumori, vol. 92, no. 4, article 361, 2006. View at Google Scholar · View at Scopus
  21. S. Chiandussi, M. Biasotto, F. Dore, F. Cavalli, M. A. Cova, and R. di Lenarda, “Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws,” Dentomaxillofacial Radiology, vol. 35, no. 4, pp. 236–243, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Borgioli, C. Viviani, M. Duvina et al., “Biphosphonates-related osteonecrosis of the jaw: clinical and physiopathological considerations,” Therapeutics and Clinical Risk Management, vol. 5, no. 1, pp. 217–227, 2009. View at Google Scholar · View at Scopus
  23. V. Kumar, B. Pass, S. A. Guttenberg et al., “Bisphosphonate-related osteonecrosis of the jaws: a report of three cases demonstrating variability in outcomes and morbidity,” The Journal of the American Dental Association, vol. 138, no. 5, pp. 602–609, 2007. View at Google Scholar · View at Scopus
  24. R. Hermans, E. Fossion, C. Ioannides, W. van den Bogaert, J. Ghekiere, and A. L. Baert, “CT findings in osteoradionecrosis of the mandible,” Skeletal Radiology, vol. 25, no. 1, pp. 31–36, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-B. Woo, J. W. Hellstein, and J. R. Kalmar, “Systematic review: bisphosphonates and osteonecrosis of the jaws,” Annals of Internal Medicine, vol. 144, no. 10, pp. 753–761, 2006. View at Google Scholar · View at Scopus
  26. M. Mortensen, W. Lawson, and A. Montazem, “Osteonecrosis of the jaw associated with bisphosphonate use: presentation of seven cases and literature review,” Laryngoscope, vol. 117, no. 1, pp. 30–34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Montebugnoli, L. Felicetti, D. B. Gissi, A. Pizzigallo, G. A. Pelliccioni, and C. Marchetti, “Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 104, no. 4, pp. 473–477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. M. Curi, G. S. I. Cossolin, D. H. Koga et al., “Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 2, pp. 349–355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. E. Marx, J. E. Cillo Jr., and J. J. Ulloa, “Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment,” Journal of Oral and Maxillofacial Surgery, vol. 65, no. 12, pp. 2397–2410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. B. J. Edwards, M. Gounder, J. M. McKoy et al., “Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw,” The Lancet Oncology, vol. 9, no. 12, pp. 1166–1172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Crépin, M.-L. Laroche, B. Sarry, and L. Merle, “Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review,” European Journal of Clinical Pharmacology, vol. 66, no. 6, pp. 547–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. I. J. Diel, I. Fogelman, B. Al-Nawas et al., “Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: is there a diverse relationship of amino- and non-aminobisphosphonates?” Critical Reviews in Oncology/Hematology, vol. 64, no. 3, pp. 198–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. van den Wyngaert, M. T. Huizing, and J. B. Vermorken, “Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?” Annals of Oncology, vol. 17, no. 8, pp. 1197–1204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. B. Nase and J. B. Suzuki, “Osteonecrosis of the jaw and oral bisphosphonate treatment,” Journal of the American Dental Association, vol. 137, no. 8, pp. 1115–1119, 1169–1170, 2006. View at Google Scholar · View at Scopus
  35. C. A. Migliorati, M. M. Schubert, D. E. Peterson, and L. M. Seneda, “Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy,” Cancer, vol. 104, no. 1, pp. 83–93, 2005. View at Publisher · View at Google Scholar · View at Scopus